Product Information
AMITRIPTYLINE HCL 150 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3070 per EA under NDC 70710123001. Its NADAC has been published 415 times since Sep 12, 2018.
FDA first approved this application on Oct 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710123001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210086FDA Approved
10/6/2017
TE Code
AB
On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 150 MG TAB has been published 415 times since Sep 12, 2018, and over the history we have for it it has declined 76.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3070 per EA |
|---|---|
| All-time high | $1.2771 (Sep 12, 2018) |
| All-time low | $0.1749 (Dec 21, 2022) |
| 52-week high | $0.3070 |
| 52-week low | $0.2222 |
| Median price | $0.3599 |
| Average price | $0.5312 |
| Largest weekly change | +55.6% (Mar 22, 2023) |
| Weeks tracked | 415 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 150 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3070 per EA (NDC 70710123001), effective Aug 19, 2026.
How has the price of AMITRIPTYLINE HCL 150 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has declined 76.0%. It has been tracked across 415 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 150 MG TAB?
Since Sep 12, 2018, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has ranged from a low of $0.1749 (Dec 21, 2022) to a high of $1.2771 (Sep 12, 2018), with a median of $0.3599 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 150 MG TAB?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMITRIPTYLINE HCL 150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 150 MG TAB?
AMITRIPTYLINE HCL 150 MG TAB (NDC 70710123001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.